Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
54m
Dupixent® (Dupilumab) Sbla Accepted For FDA Review For The Treatment Of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...
1h
Sanofi, Regeneron's Dupixent SBLA Accepted For FDA Review To Treat Chronic Spontaneous Urticaria
French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tapped for health secretary
Florida sues FEMA officials
FBI offering up to $25K
Named grand marshal
Vonn ending her retirement
To close hundreds of stores
E. coli cases climb to 104
OH trans bathroom bill
Bohannan requests recount
Ben & Jerry's sues Unilever
IN gender-affirming care ban
To run Interior Department
To replace Kotb on 'Today'
Notre Dame set to reopen
Remains ID'd after 82 years
Faces up to $165M penalty
Global increase in diabetes
Military suicides increased
Seeks pause in docs appeal
Largest coral ever recorded
China hacked telecom firms
Israel accused of war crimes
House GOP conference chair
Weekly jobless claims fall
Israeli airstrikes hit Syria
DOJ report on Fulton jail
Judge blocks name change
Bed rails recalled
Tropical Storm Sara forms
The Onion buys Infowars
EU fines Meta
CDC: OD deaths down
Feedback